First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 168.36 USD -0.7%
Updated: Apr 24, 2024
ABBV
/
Income Statement
/
Revenue

Abbvie Inc
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Revenue Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%
Seagen Inc
NASDAQ:SGEN
Revenue
$2.3B
CAGR 3-Years
7%
CAGR 5-Years
30%
CAGR 10-Years
24%

Abbvie Inc
Revenue Breakdown

Breakdown by Geography
Abbvie Inc

Total Revenue: 54.3B USD
100%
United States: 41.9B USD
77.1%
Other Countries: 5B USD
9.3%
Germany: 1.3B USD
2.3%
Canada: 1.1B USD
2%
Japan: 1B USD
1.9%
China: 950m USD
1.7%
France: 780m USD
1.4%
Spain: 501m USD
0.9%
Italy: 484m USD
0.9%
Australia: 472m USD
0.9%
Brazil: 439m USD
0.8%
Show More
Show Less

Breakdown by Segments
Abbvie Inc

Total Revenue: 54.3B USD
100%
H U M I R A: 14.4B USD
26.5%
Skyrizi: 7.8B USD
14.3%
Rinvoq: 4B USD
7.3%
Imbruvica: 3.6B USD
6.6%
Other Products: 3B USD
5.6%
Botox Therapeutic: 3B USD
5.5%
Vraylar: 2.8B USD
5.1%
Botox Cosmetic: 2.7B USD
4.9%
Venclexta: 2.3B USD
4.2%
Mavyret: 1.4B USD
2.6%
Juvederm Collection: 1.4B USD
2.5%
Other Aesthetics: 1.2B USD
2.3%
Linzess/Constella: 1.1B USD
2%
Ubrelvy: 815m USD
1.5%
Other Eye Care: 803m USD
1.5%
Ozurdex: 472m USD
0.9%
Duodopa: 468m USD
0.9%
Restasis: 436m USD
0.8%
Lumigan/Ganfort: 432m USD
0.8%
Qulipta: 408m USD
0.8%
Other Neuroscience: 276m USD
0.5%
Alphagan/Combigan: 272m USD
0.5%
Show More
Show Less

See Also

What is Abbvie Inc's Revenue?
Revenue
54.3B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Revenue amounts to 54.3B USD.

What is Abbvie Inc's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Abbvie Inc have been 6% over the past three years , 11% over the past five years , and 11% over the past ten years .

ALPHA SPREAD
Join more than 131,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.